Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy

被引：0
|
作者：
Quyen D. Chu
Meijiao Zhou
Kaelen L. Medeiros
Prakash Peddi
Mindie Kavanaugh
Xiao-Cheng Wu
机构：
[1] Department of Surgery,
[2] Louisiana State University Health Sciences Center,undefined
[3] Department of Medicine,undefined
[4] Division of Hematology and Oncology,undefined
[5] Louisiana State University Health Sciences Center,undefined
[6] Feist-Weiller Cancer Center,undefined
[7] Louisiana Tumor Registry and Epidemiology,undefined
[8] School of Public Health,undefined
[9] Louisiana State University Health Sciences Center,undefined
来源：
BMC Cancer | / 16卷
关键词：
Colon cancer; Stage IIB/C colon cancer; Stage IIIA colon cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Adjuvant Treatment is Superior to Salvage Therapy for Pathological T2-3N0M0 or T1-4N1M0/T4N0M0 Esophageal Cancer after Radical Surgery
    Ni, W.
    Yang, J.
    Xiao, Z.
    Wang, X.
    Zhou, Z.
    Zhang, H.
    Chen, D.
    Feng, Q.
    Liang, J.
    Lv, J.
    Wang, X.
    Hui, Z.
    Zhang, T.
    Bi, N.
    Deng, L.
    Wang, W.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E175 - E176
  • [22] PROGRESSION IN UNTREATED CARCINOMA OF THE PROSTATE METASTATIC TO REGIONAL LYMPH-NODES (STAGE T0 4,N1 TO 3,M0,D1)
    DAVIDSON, PJT
    HOP, W
    KURTH, KH
    FOSSA, SD
    WAEHRE, H
    SCHRODER, FH
    JOURNAL OF UROLOGY, 1995, 154 (06): : 2118 - 2122
  • [23] Is the T1/2N1 (≤3 nodes) category actually stage IIIA (TNM)/IIIa (Japanese classification) in patients with primary colorectal cancer?
    Mukai, Masaya
    Kishima, Kyoko
    Fukumitsu, Hiroshi
    Sekido, Yasutomo
    Izumi, Hideki
    Hoshikawa, Tatsuhiko
    Tajima, Takayuki
    Tobita, Kousuke
    Sadahiro, Sotaro
    Yasuda, Seiei
    Ogoshi, Kyoji
    ONCOLOGY REPORTS, 2011, 26 (01) : 209 - 214
  • [24] Adjuvant Chemotherapy for T2N1 and T3-4 Gallbladder Cancer: A Clear Benefit
    Bergquist, John R.
    Ivanics, Tommy
    Habermann, Elizabeth B.
    Kendrick, Michael L.
    Farnell, Michael B.
    Smoot, Rory L.
    Nagorney, David M.
    Truty, Mark
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : S73 - S73
  • [25] Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study
    Huang, Ze-Ning
    Desiderio, Jacopo
    Chen, Qi-Yue
    Zheng, Chao-Hui
    Li, Ping
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lin, Jian-Xian
    Lu, Jun
    Cao, Long-Long
    Lin, Mi
    Tu, Ru-Hong
    Lin, Ju-Li
    Zheng, Hua-Long
    Huang, Chang-Ming
    BMC GASTROENTEROLOGY, 2019, 19 (01)
  • [26] Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2 N0
    Tanaka, K
    Kubota, K
    Kodama, T
    Nagai, K
    Nishiwaki, Y
    ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1039 - 1042
  • [27] The lymph node ratio does not provide additional prognostic information compared with the N1/N2 classification in Stage III colon cancer
    Mohan, H. M.
    Walsh, C.
    Kennelly, R.
    Ng, C. H.
    O'Connell, P. R.
    Hyland, J. M.
    Hanly, A.
    Martin, S.
    Gibbons, D.
    Sheahan, K.
    Winter, D. C.
    COLORECTAL DISEASE, 2017, 19 (02) : 165 - 171
  • [28] Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients
    Mark F. Berry
    Brooke K. Coleman
    Lesley H. Curtis
    Mathias Worni
    Thomas A. D’Amico
    Igor Akushevich
    Annals of Surgical Oncology, 2015, 22 : 642 - 648
  • [29] Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients
    Berry, Mark F.
    Coleman, Brooke K.
    Curtis, Lesley H.
    Worni, Mathias
    D'Amico, Thomas A.
    Akushevich, Igor
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 642 - 648
  • [30] Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors
    Wang, Z.
    Yan, J.
    Hu, W.
    Zhang, J.
    Huo, B.
    NEOPLASMA, 2018, 65 (04) : 592 - 598
12345